Literature DB >> 411765

The corneal penetration of trifluorothymidine, adenine arabinoside, and idoxuridine: a comparative study.

W J O'Brien, H F Edelhauser.   

Abstract

Trifluorothymidine (F3TdR) and idoxuridine (IDU) were observed to penetrate through the cornea from the epithelial side at a greater rate than adenine arabinoside (ARA-A) during in vitro corneal perfusions. Removal of the epithelium increased the rate of penetration of F3TdR and IDU by about twofold and the rate of ARA-A penetration by fivefold. The kinetics of antiviral penetration did not display saturation points at high antiviral concentrations, thus indicating that these three antiviral drugs penetrate the cornea by nonfacilitated diffusion. The sole breakdown product detected following F3TdR penetration in vitro, in situ, and in controls was 5 carboxy-2'-deoxyuridine (5-COOH-2'-dUd). The sole breakdown product isolated during ARA-A penetration experiments was hypoxanthine arabinoside (ARA-HX), and control experiments indicated that ARA-A was stable at pH 7.6. IDU was degraded to 2'-deoxyuridine (dUd) in control experiments, but during corneal penetration experiments IDU was degraded to a mixture of dUd and iodouracil (IU).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411765

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Predicted permeability of the cornea to topical drugs.

Authors:  A Edward; M R Prausnitz
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

Authors:  C S Rao; R D Schoenwald; C F Barfknecht; S L Laban
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

3.  Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.

Authors:  Y B Chung; K Han; A Nishiura; V H Lee
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

4.  Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.

Authors:  Shun Han; Jin-qiu Shen; Yong Gan; Hai-ming Geng; Xin-xin Zhang; Chun-liu Zhu; Li Gan
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

5.  The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure.

Authors:  Hui Yang; Marcel Y Avila; Kim Peterson-Yantorno; Miguel Coca-Prados; Richard A Stone; Kenneth A Jacobson; Mortimer M Civan
Journal:  Curr Eye Res       Date:  2005-09       Impact factor: 2.424

Review 6.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

Review 7.  A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1.

Authors:  Sara M Thomasy; David J Maggs
Journal:  Vet Ophthalmol       Date:  2016-04-19       Impact factor: 1.644

8.  Herpetic iridocyclitis.

Authors:  K R Wilhelmus; M G Falcon; B R Jones
Journal:  Int Ophthalmol       Date:  1982-02       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.